Our Process

A structured, six-phase development process grounded in design controls, risk rigor, and verification discipline. Our process is designed for real-world product development: technical de-risking early, verification evidence that maps to requirements, validation activities that support intended use, and a clean path into design transfer—aligned with FDA expectations and ISO 13485 practices.

Phase 1: 
Feasibility & Planning

Define the requirements, intended use, and regulatory pathway (e.g. 510(k) or De Novo). Build the development plan, early risk posture, and requirements so scope, cost, and timelines stay predictable. Technical de-risking of concept(s) through focused alpha prototyping and early feasibility testing.

1

Process Image

Phase 2: 
Development

Turn requirements into a buildable design: architecture, CAD, prototyping, supplier strategy, and design outputs—while keeping traceability, risk controls, and documentation moving in parallel.

2

Process Image

Phase 3: 
Design Verification

Prove the design meets requirements with right-sized verification planning, test method development (as needed), and execution that produces clean, reviewable evidence—not just raw data. When appropriate, we also run early manufacturing pilot builds of test articles to support verification testing and uncover build/assembly risks before design transfer.

3

Process Image

Phase 4: 
Design Validation

Confirm the device works for users and the intended use case—usability/human factors and validation activities that hold up to scrutiny. We build the submission package throughout development, and typically submit to FDA toward the end of this phase (e.g., 510(k) or De Novo).

4

Process Image

Phase 5: 
Design Transfer

Convert the design into a controlled, repeatable manufacturing process: DMR/DHR readiness, process validation planning, incoming inspection, fixtures/tooling, and quality controls.

5

Process Image

Phase 6: 
Commercialization

Launch with execution discipline—final documentation, readiness reviews, manufacturing scale-up, and post-launch support to keep quality, cost, and delivery on track.

6

Process Image
border line

Frequently Asked Questions

No. We’re happy to work within your existing Design Control process or use our own, depending on what makes the most sense for your team. If you already have an established QMS, we can integrate seamlessly into your phases, deliverables, and documentation requirements.

A patent is not needed to begin a partnership with Ontogen and start designing, building, and testing.  Our Client Agreement ensures Confidentiality of your device ideas and intellectual property.

User feedback is vital to our process. We engage with end-users early and often through informal focus groups and formative usability testing to ensure the final product meets their needs and expectations.

Our Client Agreement ensures that you retain 100% ownership of all the work product we create, including designs, schematics, intellectual property, etc.

Take the next step to success

Medical device development can be daunting-- we are here to help.

Schedule A Free Consultation